Clinical features of anti-N-methyl-D-aspartate receptor encephalitis and the concomitant seizure.
10.11817/j.issn.1672-7347.2019.05.011
- Author:
Lingchao WU
1
;
Chongyu HU
2
;
Lili LONG
1
;
Xiaoyan LONG
1
;
Jing LI
1
;
Weiping LIU
1
;
Fangfang BI
1
;
Bo XIAO
1
Author Information
1. Department of Neurology, Xiangya Hospital, Central South University, Changsha 410008, China.
2. Department of Neurology, Hunan Provincial People's Hospital, Changsha 410005, China.
- Publication Type:Journal Article
- MeSH:
Anti-N-Methyl-D-Aspartate Receptor Encephalitis;
Humans;
Immunotherapy;
Magnetic Resonance Imaging;
Receptors, N-Methyl-D-Aspartate;
Seizures
- From:
Journal of Central South University(Medical Sciences)
2019;44(5):544-548
- CountryChina
- Language:Chinese
-
Abstract:
To investigate the clinical features, auxiliary examination and characteristics for anti-N-methyl-D-aspartate receptor (anti-NMDAR) encephalitis and its concomitant seizure.
Methods: A total of 20 patients diagnosed as anti-NMDAR encephalitis were enrolled from January 2016 to September 2018 in Xiangya Hospital. The data including the clinical features, auxiliary examination, characteristics of seizure, treatment and prognosis were collected. The discharged patients were followed up for half a year.
Results: The initial symptom in patients with anti-NMDAR encephalitis were mainly psychiatric symptom and seizure. Most of the EEG result were diffused slow waves. The mainly type of seizure in patients with anti-NMDAR encephalitis showed generalized tonic-clonic seizure. Patients occurred consciousness during the onset of the disease. MRI showed that patients with temporal lobe were more inclined to occur seizure than patients with anti-NMDAR encephalitis (P<0.05). After standardized treatment, 20 patients showed a significant improvement in modified Rankin Scale (mRS) scores and the seizure was under control within half a year.
Conclusion: Patients with temporal lobe affected in MRI should pay attention to the possibility of seizure occurrence. Anti-epileptic drugs and immunotherapy should be used promptly in patient with seizure. After standardized treatment, the prognosis of patients will be mostly good.
